Iron Path Capital-backed VION Biosciences Acquires Aldon Corporation
August 7, 2023
Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.
- Buyers
- VION Biosciences, Iron Path Capital
- Targets
- Aldon Corporation
- Platforms
- VION Biosciences
- Industry
- Manufacturing
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.